Application of high molecular weight oat beta-glucan extract

The invention discloses a high-molecular-weight oat beta-glucan extract which is characterized in that the content of beta-glucan with the relative molecular mass larger than or equal to 300 kDa is larger than or equal to 95%, and the high-molecular-weight oat beta-glucan extract has the effect of r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ZHANG ZHENHUI, LI BING, WU HONG, LI LIN, CAI JIAXIAN, WU YI, ZHANG XIA, WU YONGTAI
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	FODDER FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention discloses a high-molecular-weight oat beta-glucan extract which is characterized in that the content of beta-glucan with the relative molecular mass larger than or equal to 300 kDa is larger than or equal to 95%, and the high-molecular-weight oat beta-glucan extract has the effect of relieving abnormal glycolipid metabolism induced by food-borne advanced glycation end products. The high molecular weight oat beta-glucan extract is obtained by pretreatment, extraction, concentration, separation, adsorption, nanofiltration, drying and determination. The weight and blood sugar of a food-borne advanced glycation end product induced model animal can be obviously reduced by 19-25% and 8-21%, the oral glucose tolerance impairment of the model animal can be obviously relieved by 9-17%, and the insulin resistance can be obviously inhibited; and fat accumulation in abdominal adipose tissue, perirenal adipose tissue, epididymal adipose tissue and mesenteric adipose tissue of a model animal is remarkably inh